Advertisement

Topics

Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line ...

02:18 EST 9 Nov 2018 | BioMedReports - Blog

SUZHOU, China, Nov. 9, 2018 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 1801), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs,

Read more...

Original Article: Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line ...

NEXT ARTICLE

More From BioPortfolio on "Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...